ES549115A0 - Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores - Google Patents

Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores

Info

Publication number
ES549115A0
ES549115A0 ES549115A ES549115A ES549115A0 ES 549115 A0 ES549115 A0 ES 549115A0 ES 549115 A ES549115 A ES 549115A ES 549115 A ES549115 A ES 549115A ES 549115 A0 ES549115 A0 ES 549115A0
Authority
ES
Spain
Prior art keywords
viii
pct
inhibitor
cag
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549115A
Other languages
English (en)
Other versions
ES8701230A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordisk Gentofte AS
Original Assignee
Nordisk Gentofte AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte AS filed Critical Nordisk Gentofte AS
Publication of ES549115A0 publication Critical patent/ES549115A0/es
Publication of ES8701230A1 publication Critical patent/ES8701230A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES549115A 1984-11-05 1985-11-05 Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores Expired ES8701230A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK525384A DK525384D0 (da) 1984-11-05 1984-11-05 Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat

Publications (2)

Publication Number Publication Date
ES549115A0 true ES549115A0 (es) 1986-12-01
ES8701230A1 ES8701230A1 (es) 1986-12-01

Family

ID=8140859

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549115A Expired ES8701230A1 (es) 1984-11-05 1985-11-05 Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores

Country Status (11)

Country Link
US (1) US4831119A (es)
EP (1) EP0201574B1 (es)
JP (1) JPH0713026B2 (es)
AT (1) ATE69727T1 (es)
AU (1) AU599310B2 (es)
CA (1) CA1269042A (es)
DE (1) DE3584775D1 (es)
DK (1) DK525384D0 (es)
ES (1) ES8701230A1 (es)
IL (1) IL76929A (es)
WO (1) WO1986002838A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
EP0251843A1 (fr) * 1986-06-06 1988-01-07 Transgene S.A. Procédé de préparation de facteur VIII à partir de cellules de mammifères
AU2473388A (en) * 1987-11-16 1989-06-22 Scripps Clinic And Research Foundation Treatment of factor viii inhibitors
DE69016656T2 (de) * 1989-06-15 1995-05-24 Smith Jun Vorrichtung zur inaktivierung infektioeser erreger und zur verhinderung der koagulierung in biologischen flüssigkeiten.
ATE233100T1 (de) * 1989-08-02 2003-03-15 Mitra Medical Technology Ab System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
EP1359935A1 (en) * 2001-02-05 2003-11-12 Novo Nordisk Health Care AG Combined use of factor vii polypeptides and factor ix polypeptides
WO2004075923A2 (en) * 2003-02-26 2004-09-10 Nektar Therapeutics Al, Corporation Polymer-factor viii moiety conjugates
ES2333598T5 (es) * 2003-05-06 2013-09-04 Biogen Idec Hemophilia Inc Proteinas quimericas del factor de coagulacion fc para tratar la hemofilia.
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
WO2006003183A1 (de) * 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
TWI828269B (zh) 2013-03-15 2024-01-01 美商百歐維拉提夫治療公司 因子ix多肽調配物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
AU555305B2 (en) * 1982-09-29 1986-09-18 Bayer Corporation Antihemophilic factor concentrate
US4406886A (en) * 1983-01-14 1983-09-27 University Patents, Inc. Purification of antihemophilia factor VIII by precipitation with zinc ions
US4649132A (en) * 1983-03-31 1987-03-10 Scripps Clinic And Research Foundation Treatment of Factor VIII inhibitors
DE3481109D1 (de) * 1983-05-09 1990-03-01 Novo Nordisk As Antihaemophilie-faktor-viii-konzentrat und dessen herstellungsverfahren.
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
FI852866L (fi) * 1984-07-27 1986-01-28 Meloy Lab Rekombinantfaktor viii-r.

Also Published As

Publication number Publication date
CA1269042A (en) 1990-05-15
AU5092685A (en) 1986-06-03
IL76929A0 (en) 1986-04-29
JPH0713026B2 (ja) 1995-02-15
DE3584775D1 (de) 1992-01-09
WO1986002838A1 (en) 1986-05-22
DK525384D0 (da) 1984-11-05
ES8701230A1 (es) 1986-12-01
EP0201574B1 (en) 1991-11-27
AU599310B2 (en) 1990-07-19
ATE69727T1 (de) 1991-12-15
EP0201574A1 (en) 1986-11-20
IL76929A (en) 1990-07-26
US4831119A (en) 1989-05-16
JPS62501006A (ja) 1987-04-23

Similar Documents

Publication Publication Date Title
RU95115239A (ru) Аналог эритропоэтина
DE3584775D1 (de) Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
DK0662827T4 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
YU34196A (sh) Peptidi i jedinjenja koja se vezuju za receptor
KR880701246A (ko) 재조합 페포 계면활성제 단백질
KR880003975A (ko) 항응고성 및 항전이성을 갖는 단백질
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
Mebs et al. Snake venom hemorrhagins: neutralization by commercial antivenoms
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
DE69607034D1 (de) Pcna bindende substanz
Guisasola et al. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity
MX9304925A (es) Composiciones terapeuticas contra el cancer para profilaxis o para el tratamiento de cancer.
AU3595489A (en) Amblyommin, a new active substance for anticoagulant therapy
BRPI0416461A (pt) método para o tratamento de episódios de sangramento, formulação farmacêutica, e, uso de um polipeptìdeo fxi
PT804182E (pt) Utilizacao de gabapentina para o tratamento da ansiedade e do panico
NO991653L (no) Immunogenisk tumor frigjorte partikler (TLP)-blanding
Araujo et al. Potentiation of bradykinin action on smooth muscle by a scorpion venom extract
DK318086A (da) Praeparat til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadant praeparat
Tillement et al. Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro
BR9006746A (pt) Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio